GLASGOW, SCOTLAND- OCTOBER 19: Slot machines are seen in an amusement arcade following the ... [+] announcement of the newly proposed gambling bill which will effect casinos and amusement arcades across the UK, October 19, 2004 in Glasgow, Scotland. The new law if approved by the government will allow casinos with over 1,250 slot machines unlimted jackpots, currently Britain has 126 casinos with slot machine winnings being limited to GBP2,000. (Photo by Christopher Furlong /Getty Images) *** Local Caption ***
Statistics from the North American Foundation for Gambling Addiction and Help estimate that more than 2.6% of Americans struggle with some form of gambling abuse, and many opponents of the expanding sports betting marketplace argue that few measures have been put in place to aid the more than 10 million people battling this addiction.
The overturn of the Professional and Amateur Sports Protection Act (PASPA) the US federal government awarded individual states with the ability to legalize and regulate sports betting in their respective jurisdictions. In doing so, each state has also been given the responsibility to establish clear methods to both prevent, identify, and offer help to those labeled as problem gamblers.
Many sportsbook operators give customers the ability to pause their accounts and to establish self imposed limits, but outside of support groups and dial-in hotlines, few true solutions exist to aid those looking for help.
New research is currently being conducted by a prominent biotech company to explore ketamine as a potential remedy for compulsive behaviors and more specifically gambling addiction.
Awakn Life Sciences has brought on the expertise of Dr. David Nutt, psychiatrist and Edmund J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept of Medicine, Imperial College London. In doing so, the Awakn team has announced their plans to conduct the first clinical examination of ketamine and gambling addictions.
As a psychopharmacologist, Dr. Nutt has made it his lifes work to study the effects of drugs on the brain. Over the last 15 years I've started studying psychedelics, opens Dr. Nutt, largely because very few people were and I thought it was something someone had to do.
While on this 15-year journey, Dr. Nutt found it particularly interesting that little had been done to advance the research conducted more than a half century ago focused on psychedelics and their impact on brain disorders.
It turned out that studying psychedelics opened up a whole new set of possibilities for treating mental disorders that I hadn't thought of before, partly because I didn't know the literature. It's only now that I've gone back to the 1950s and 60s and discovered there was quite a lot of interest then in treating addiction, particularly alcoholism with psychedelics, then.
Much like gambling, psychedelics cary many unfair social stigmatism, with the act of sports betting just recently making the leap from a taboo, degenerative behavior to a socially acceptable one over the last three years.
Where one could easily argue that the pandemic expedited the spread of sports betting regulation and its public acceptance, the increased emphasis on mental health has also thrust the psychedelic therapeutics industry back into the spotlight. Unbeknownst to many, the two industries might be more connected than one might think.
Our modern imaging work showed that psychedelics disrupt a circuit in the brain that seems to be overactive in conditions like depression. And it's also overactive in conditions where, and probably any condition where people get over engaged in thinking about a single thought.
So in depression, continues Dr. Nutt, depressed people are thinking about mistakes they've made. They're thinking about having low self esteem, etc. And of course, in addiction, people are thinking about the next chance they get to drink or to shoot up or to gamble.
Those in Dr. Nutts field of study often use the term internalizing disorders when labeling this kind of thought process. As he dove deeper, Dr. Nutt had the revelation that the processes of disrupting internal thinking and depression could potentially disrupt the internal thinking in addiction as well.
Dr. Nutt acknowledges that he was not the first to come to this conclusion, referencing the Bogenschutz study in New Mexicos look into alcoholism, and the ongoing clinical trials at Johns Hopkins targeting psychedelics therapeutics for smoking cessation.
So now we've got the neuroscience of psychedelics and some clinical data. Why not bring them together?
The opportunity to make this connection came when Awakn Life Sciences extended Dr. Nutt an offer to join as the groups Chief Research Officer, granting him access to the funding necessary to conduct this research.
Awakn has focused most of its research on the battle against addiction, and gambling addiction presented itself as a prime candidate for the studys efforts. Similarly to the research being conducted at Johns Hopkins for smoking cessation, gambling addiction is viewed as more of a raw addiction that has less outside influences condemning or reinforcing the compulsive action.
We've been studying gambling on the grounds that it's an addiction that isn't confounded by drug use, added Dr. Nutt, suggesting that other chemical dependencies often come with a wide variety of variables that potentially disrupt scientific findings. These substances also produce an obvious biological reaction in the human brain.
Gambling addiction can be difficult to detect, as the problem bettor can often maintain a relatively normal lifestyle. Alcoholics and opiate addicts, for comparison, regularly see their substance dependency impact their personal and professional lives, creating outside stressors and factors that can skew a studys results.
When asked why Awakn had chosen ketamine as the leading candidate, Dr. Nutt points to the most obvious of reasons; Its legal.
Ketamine has long been used as an anesthetic, and the psychoactive chemical is often administered to relieve pain and even induce the loss of consciousness. Given its wide acceptance in the medical community, ketamine was an obvious choice for the study given that it can be both prescribed and put into practice right away.
Ketamine is basically an easily accessible, inexpensive, sort of psychedelic, adds Dr. Nutt. But while it may not be as powerful as psychedelics as drugs like psilocybin or DMT, it's psychedelic enough. It definitely disrupts brain function during the trip, and it seems to be just enough in terms of alcoholism to allow people to recover. So maybe what we can do with setting up this trial is to see if it produces the same disruption in people who are gambling compulsively.
Ketamine is already widely used in the United States to treat depression, but Awakn is seeking to construct a manualized approach to incorporate the chemical into a three-dose psychotherapeutic regimen.
This revolutionary study hopes to provide substantiated evidence and data that supports an abstinence based psychotherapy process using ketamine to curb, and even eliminate these compulsive brain patterns.
What we're hoping is that we can develop and prove that a systematic form of administration and psychotherapy is effective, wed be able to license that as an indicator as a mode of treatment without necessarily having to license the medicine.
Go here to see the original:
Defeating Gambling Addiction: New Study Looks To Defy The Odds With Psychedelics - Forbes
- Review: Tripping on Utopia Complicates the History of Psychedelics - AOL - March 16th, 2024 [March 16th, 2024]
- Psychedelics Are Going Mainstream. Investing in Them Hasn't. - The Wall Street Journal - January 7th, 2024 [January 7th, 2024]
- Another Study Shows African Psychedelic Plant Ibogaine Treats Traumatic Brain Injury in Vets With 'Dramatic' Results - Good News Network - January 7th, 2024 [January 7th, 2024]
- Massachusetts Lawmakers Will Be Forced To Consider Psychedelics Legalization Measure That Activists Petitioned ... - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA to begin researching psychedelics as treatment option for veterans - Government Executive - January 5th, 2024 [January 5th, 2024]
- VA Is Funding New Research On Psychedelics' Benefits For Veterans With PTSD And Depression - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA ramps up study of psychedelic to treat PTSD - The American Legion - January 5th, 2024 [January 5th, 2024]
- Scientists predict DMT trip from cardiac activity - Big Think - January 5th, 2024 [January 5th, 2024]
- If psychedelics heal, how do they do it? | Proceedings of the National Academy of Sciences - pnas.org - January 5th, 2024 [January 5th, 2024]
- Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential | Molecular ... - Nature.com - January 5th, 2024 [January 5th, 2024]
- U.S. Rep. Correa supports using psychedelics to treat veterans with PTSD - New Santa Ana - January 5th, 2024 [January 5th, 2024]
- DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Psychedelics for Psych Conditions Made Their Mark in 2023 - Medpage Today - January 5th, 2024 [January 5th, 2024]
- 2023: A Good Trip Around the Sun for Psychedelics - The National Law Review - January 5th, 2024 [January 5th, 2024]
- Understanding the Role of the FDA in Advancing Psychedelic Therapy - Medriva - January 5th, 2024 [January 5th, 2024]
- MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics - Psychedelic Alpha - January 5th, 2024 [January 5th, 2024]
- Closing the innovation gap: Advancing psychedelic therapy and medicines in EU mental health care - Open Access Government - January 5th, 2024 [January 5th, 2024]
- The Austin Chronic: SXSW Is High on Psychedelics, as Cannabis Programming Wanes - Austin Chronicle - January 5th, 2024 [January 5th, 2024]
- This Forgotten Psychedelic Could Revolutionize Traumatic Brain Injury Treatment - Inverse - January 5th, 2024 [January 5th, 2024]
- A 'milestone' for psychedelics: Pentagon directed to study alternative treatments for veterans - Washington Times - January 5th, 2024 [January 5th, 2024]
- Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here's What's Next - Singularity Hub - January 5th, 2024 [January 5th, 2024]
- The top 8 psychedelic books you need to read | GreenState - GreenState - January 5th, 2024 [January 5th, 2024]
- Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC - Green Market Report - January 5th, 2024 [January 5th, 2024]
- DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024 - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Here's What You Missed in Cannabis, Psychedelics This Week - TipRanks.com - TipRanks - January 5th, 2024 [January 5th, 2024]
- You're not tripping: State and local leaders give psychedelics another chance - Route Fifty - December 22nd, 2023 [December 22nd, 2023]
- Are Consciousness-Expanding Psychedelics Like Psilocybin More Effective Than Prozac, Zoloft, Xanax, and Other ... - Nautilus - December 22nd, 2023 [December 22nd, 2023]
- RFK, Ramaswamy And Williamson Push Psychedelics Reform On Presidential Campaign Trail - Marijuana Moment - December 22nd, 2023 [December 22nd, 2023]
- Peyote is the darling of the psychedelics renaissance. Indigenous users say it co-opts a sacred way of life - The Guardian US - December 22nd, 2023 [December 22nd, 2023]
- USask researchers explore untold history of psychedelics - News - University of Saskatchewan - USask News - December 22nd, 2023 [December 22nd, 2023]
- California Governor Says Psychedelics Have 'Profound' Healing Potential, But He's Undecided On Legalization Bill As ... - Marijuana Moment - September 25th, 2023 [September 25th, 2023]
- As psychedelic-assisted therapy grows, so does interest from a new group: chaplains - NPR - September 25th, 2023 [September 25th, 2023]
- This Maine City Moves Unanimously On Decriminalizing Psychedelics: Focus On Public Health - Benzinga - September 25th, 2023 [September 25th, 2023]
- Tech Leaders Are Finding Balance Through Microdosing Psychedelics - The Dales Report - September 25th, 2023 [September 25th, 2023]
- Chronic Pain Can Be Treated by Psychedelics, Survey Suggests - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Insights Into the First Psychedelic-Assisted Therapy Guidelines With ... - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Living with long-term cancer is depressing. Texas doctors say psychedelics could help - The Hill - July 19th, 2023 [July 19th, 2023]
- Couples Are Doing MDMA and Ketamine Therapy To Save Their Relationships - VICE - July 19th, 2023 [July 19th, 2023]
- The Way People Are Using Psychedelics Is Changing Amid Reform ... - Marijuana Moment - July 19th, 2023 [July 19th, 2023]
- [WATCH] Turn on, tune in, legalise: Could psychedelics be next in ... - MaltaToday - July 19th, 2023 [July 19th, 2023]
- Will Psychedelics Be Rescheduled After FDA Approval? - Harris Bricken - July 19th, 2023 [July 19th, 2023]
- The Psychedelic Preparedness Scale: A Tool to Optimize Trip ... - Filter - July 19th, 2023 [July 19th, 2023]
- How to Test Psychedelics for Adulterants with Testing Kits - Psychedelic Spotlight - July 19th, 2023 [July 19th, 2023]
- Cannabis Science Conference to debut in Providence, R.I., with ... - GlobeNewswire - July 19th, 2023 [July 19th, 2023]
- New Speaker Rivas weighs in on psychedelics, housing and health care worker minimum wage - Yahoo News - July 19th, 2023 [July 19th, 2023]
- TDR's Top 5 Psychedelic Developments For The Week Of July 10 - The Dales Report - July 19th, 2023 [July 19th, 2023]
- Psychedelic Treatment with Psilocybin Relieves Major Depression, Study ... - February 20th, 2023 [February 20th, 2023]
- Johns Hopkins Launches Center For Psychedelic Research - February 20th, 2023 [February 20th, 2023]
- Psilocybin Treatment for Major Depression Effective for Up to a Year ... - February 20th, 2023 [February 20th, 2023]
- Inside the Johns Hopkins Psilocybin Playlist - Hopkins Medicine - February 20th, 2023 [February 20th, 2023]
- Research Story Tip: Psychedelic Drug Psilocybin Tamps Down Brains Ego ... - February 20th, 2023 [February 20th, 2023]
- Psychedelics: Risks, benefits, and more - Medical News Today - February 18th, 2023 [February 18th, 2023]
- Psychedelic Drug Effects, Side Effects & Dangers - January 25th, 2023 [January 25th, 2023]
- Psychedelics Decriminalization Project In Berkeley, Cal Includes ... - January 6th, 2023 [January 6th, 2023]
- Ancient mummified child was drugged with psychedelics before ritual ... - December 14th, 2022 [December 14th, 2022]
- The therapeutic potential of psychedelics - Science - December 14th, 2022 [December 14th, 2022]
- Changing Lives with Psychedelics: How Connecticut researchers are using magic mushrooms to help people overcome depression, OCD - WTNH.com - November 19th, 2022 [November 19th, 2022]
- Penis Envy Mushroom | Legal Psychedelics | Magic Mushroom - November 7th, 2022 [November 7th, 2022]
- Psychedelics. Discussing natural and synthetic friends. Science, News ... - November 5th, 2022 [November 5th, 2022]
- The Harms of Psychedelics Need to Be Put Into Context - WIRED - November 5th, 2022 [November 5th, 2022]
- Packers' Aaron Rodgers says psychedelics led to his back-to-back MVP ... - October 28th, 2022 [October 28th, 2022]
- With Promise of Legalization, Psychedelic Companies Joust Over Future Profits - The New York Times - October 25th, 2022 [October 25th, 2022]
- How do psychedelics work? This brain region may explain their effects - PBS - October 21st, 2022 [October 21st, 2022]
- Why is the American right suddenly so interested in psychedelic drugs? - The Guardian - October 19th, 2022 [October 19th, 2022]
- Can Psychedelics Cure? Science Is on the Verge of Finding Out - Newsweek - October 19th, 2022 [October 19th, 2022]
- Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development - PsyPost - October 19th, 2022 [October 19th, 2022]
- This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More - Small Pharma - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Made the Mushrooms Magic: Psychedelic Study Explores the Odd Evolution of Mind-Altering Fungi - The Debrief - October 19th, 2022 [October 19th, 2022]
- Psychedelics And Wellness: The Healing Company Buys PepsiCo-Backed Superfoods Company - (HLCO) - Benzinga - October 19th, 2022 [October 19th, 2022]
- What's on the Colorado ballot? Housing, psychedelics, school meals, alcohol, taxes and more | FOX31 Denver - FOX 31 Denver - October 19th, 2022 [October 19th, 2022]
- DoseConnect to Sponsor the Tech Stage at Wonderland Miami by Microdose - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Is Going on With Bright Minds (DRUG) Stock Today? - InvestorPlace - October 19th, 2022 [October 19th, 2022]
- Psychedelics May Ease Fear of Death and Dying - October 17th, 2022 [October 17th, 2022]
- TDR's Top 5 Psychedelic Developments For The Week Of October 10 - The Dales Report - October 17th, 2022 [October 17th, 2022]
- DEA Wants To Boost Production Of Cannabis & Psychedelics For Research In 2023 - Benzinga - October 17th, 2022 [October 17th, 2022]
- Talk set to explore psychedelics and mental health - Reading Today - October 17th, 2022 [October 17th, 2022]
- Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- How does psilocybin rewire the brain? - Open Access Government - October 17th, 2022 [October 17th, 2022]
- HYTN Awarded Controlled Drugs and Substances Dealers License Allowing for Production and Sale of Psilocybin - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- The Healing Company acquires leading superfoods business, Your Super, and lands $150M credit facility to expand community of brands - Yahoo Finance - October 17th, 2022 [October 17th, 2022]